Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lenalidomide, Cyclophosphamide, and Dexamethasone in AL Amyloidosis
NCT00981708Phase 2Completed
- Sponsor
- National and Kapodistrian University of Athens
- Start
- Feb 2008
- Primary completion
- Jan 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of lenalidomide in primary systemic amyloidosis, sponsored by National and Kapodistrian University of Athens. Started Feb 2008; status: completed.
02
Drugs
lenalidomide
03
Conditions
primary systemic amyloidosis
Beyond the preview
Go deeper on NCT00981708.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00981708.